Published in Breast Cancer Res on June 17, 2010
Joint effects of nulliparity and other breast cancer risk factors. Br J Cancer (2011) 0.99
Remodeling of endogenous mammary epithelium by breast cancer stem cells. Stem Cells (2012) 0.88
DNA damage and breast cancer. World J Clin Oncol (2011) 0.85
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress. PLoS One (2013) 0.78
Methods of Cell Propulsion through the Local Stroma in Breast Cancer. Int J Breast Cancer (2014) 0.76
Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone. Horm Cancer (2013) 0.76
Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Inflammation and cancer. Nature (2002) 53.78
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Inflammation and metabolic disorders. Nature (2006) 33.33
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Mammographic density and the risk and detection of breast cancer. N Engl J Med (2007) 14.32
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88
Stromal fibroblasts in cancer initiation and progression. Nature (2004) 11.69
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23
Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A (2004) 7.96
Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52
Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst (1995) 5.35
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev (1996) 5.17
Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol (2001) 4.99
Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol (1976) 4.98
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr (2006) 4.72
Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol (1994) 3.68
Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer (1976) 3.37
Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med (2005) 3.29
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Postnatal mammary gland development requires macrophages and eosinophils. Development (2000) 3.10
Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem (2004) 3.01
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96
Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab (1973) 2.91
Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia (2002) 2.90
Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology (2009) 2.57
Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol (1999) 2.52
Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer (2006) 2.52
Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res (2003) 2.48
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer (2007) 2.45
Molecular links between obesity and breast cancer. Endocr Relat Cancer (2006) 2.44
The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol (2000) 2.42
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest (2005) 2.38
Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res (2003) 2.37
Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev (2001) 2.35
Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene (2003) 2.27
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol (2001) 2.26
Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res (2009) 2.25
Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07
Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol (2001) 2.03
Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes (2002) 2.00
Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis. Int J Cancer (2009) 1.88
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol (2006) 1.83
A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev (2002) 1.78
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res (2009) 1.78
Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev (2000) 1.72
Human breast development. J Mammary Gland Biol Neoplasia (2000) 1.71
In vivo regulation of lipolysis in humans. J Lipid Res (1994) 1.70
Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development (2000) 1.70
Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res (1985) 1.70
Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res (2007) 1.66
Age at any birth and breast cancer risk. Int J Cancer (1983) 1.65
Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem (2000) 1.65
Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol (1998) 1.64
Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol (1984) 1.62
Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res (2009) 1.58
Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. Nat Biotechnol (1998) 1.58
Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol (2002) 1.56
Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia (2009) 1.55
Body mass and stage of breast cancer at diagnosis. Int J Cancer (2002) 1.54
Pregnancy-associated breast cancer. Isr Med Assoc J (2008) 1.53
Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res (2006) 1.51
Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J (2002) 1.51
Breast cancer in adolescents and young women. Eur J Cancer (2003) 1.49
Evidence for a crossover in breast cancer risk factors. Am J Epidemiol (1982) 1.49
A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development (2003) 1.48
Mammary ECM composition and function are altered by reproductive state. Mol Carcinog (2004) 1.48
Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol (2008) 1.36
Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am J Physiol Endocrinol Metab (2004) 1.35
Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech (2001) 1.35
Aromatase expression in health and disease. Recent Prog Horm Res (1997) 1.35
Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia (2009) 1.32
Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene (1997) 1.30
Leptin receptor expression and cell signaling in breast cancer. Int J Oncol (2006) 1.27
Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study. Clin Breast Cancer (2003) 1.27
The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer (1995) 1.27
Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol (2002) 1.25
Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol (1985) 1.25
Delayed involution of the mammary epithelium in BALB/c-p53null mice. Oncogene (1998) 1.25
Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst (1983) 1.23
Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Res Treat (2006) 1.21
Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer (1997) 1.19
Epidemiology of breast cancer. Findings from the nurses' health study. Cancer (1993) 1.18
Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest (2000) 1.18
Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res (1992) 1.17
Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer (1988) 1.14
Tumor biology of breast cancer in young women. Breast Dis (2006) 1.13
Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res (2001) 1.10
Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res (2007) 1.10
Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res Treat (2002) 1.05
Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3. Mol Endocrinol (2002) 1.03
Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol (2007) 1.01
Dual effect of parity on breast cancer risk. Eur J Cancer (1994) 1.01
Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology (1998) 1.01
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res (2008) 7.65
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell (2011) 7.30
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A (2011) 5.53
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70
Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell (2011) 4.08
A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res (2009) 2.84
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A (2010) 2.46
Reconstruction of human mammary tissues in a mouse model. Nat Protoc (2006) 2.03
Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A (2011) 2.01
Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell (2010) 1.92
Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res (2010) 1.90
The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell (2013) 1.75
Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res (2007) 1.66
Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? Breast Cancer Res (2007) 1.57
Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene (2003) 1.51
Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labeled circulating cells. J Biomed Opt (2007) 1.46
Stroma in breast development and disease. Semin Cell Dev Biol (2009) 1.36
GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol Med (2013) 1.33
Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression. Cancer Res (2007) 1.32
Stroma: tumor agonist or antagonist. Cell Cycle (2005) 1.28
Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice. Proc Natl Acad Sci U S A (2009) 1.23
Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells. PLoS One (2011) 1.16
Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res (2013) 1.14
Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol (2006) 1.10
Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol (2008) 1.10
Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res (2012) 1.09
Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Cancer Res (2007) 1.08
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Res (2012) 0.99
Assessment of the role of circulating breast cancer cells in tumor formation and metastatic potential using in vivo flow cytometry. J Biomed Opt (2011) 0.96
SLUG: Critical regulator of epithelial cell identity in breast development and cancer. Cell Adh Migr (2014) 0.94
Using defined finger-finger interfaces as units of assembly for constructing zinc-finger nucleases. Nucleic Acids Res (2013) 0.91
Complex prolactin crosstalk in breast cancer: new therapeutic implications. Mol Cell Endocrinol (2009) 0.89
Cyclin D1 activity regulates autophagy and senescence in the mammary epithelium. Cancer Res (2012) 0.87
Stromal biomarkers in breast cancer development and progression. Clin Exp Metastasis (2012) 0.86
Stem cell maintenance of the mammary gland: it takes two. Cell Stem Cell (2011) 0.84
Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobules. Breast Cancer Res (2014) 0.81
Prolactin promotes mammary pathogenesis independently from cyclin D1. Am J Pathol (2012) 0.78
Pregnancy-associated breast cancers are driven by differences in adipose stromal cells present during lactation. Breast Cancer Res (2014) 0.76
The evolving paradigm of tissue-specific metastasis. Breast Cancer Res (2005) 0.75
Humanization of the mouse mammary gland. Methods Mol Biol (2015) 0.75